Preferences help
enabled [disable] Abstract
Number of results
2015 | 62 | 4 | 923-928
Article title

Physical state of human papillomavirus type 16 in cervical intraepithelial lesions and cancers determined by two different quantitative real-time PCR methods

Title variants
Languages of publication
The aim of this study was to analyse the correlation between a new multiplex qPCR assay and a reference qPCR assay for assessment of the human papillomavirus (HPV16) load and the viral genome status. The study was performed on 100 HPV16 positive samples containing premalignant lesions and carcinomas. HPV16 E2 and E6 gene loads were assessed by two PCR methods. The load of E2 and E6 was normalized to the cell number by qPCR targeting the RNase P open reading frame. The physical state of the viral genome was determined as a ratio of E2/E6 copies number per cell. Among 100 samples analysed, there were no statistically significant differences in the E2 and E6 viral load evaluated by multiplex qPCR and qPCR, the correlation coefficients were 0.98 and 0.97, respectively. There were 19% of samples with the integrated, 73% with mixed and 8% with episomal state of viral genome detected by multiplex qPCR and 17%, 79%, 4%, respectively, found by qPCR. Prevalence of integrated and episomal forms estimated by multiplex qPCR was higher than the one obtained by qPCR (Chi2, p < 0.0001), but in samples with premalignant and malignant diagnoses no significant differences were demonstrated regardless of the methods used. Sensitivity and specificity of multiplex qPCR were 93.7% and 100% as compared with qPCR, the positive predictive value was 100%. In summary, the multiplex qPCR assay in respect of HPV16 load and the frequency of viral genome status was shown to be a sensitive and specific reference method. Simultaneous estimation of E2 and E6 genes in one reaction tube reduces the cost of testing.
Physical description
  • Department of Virology, Chair of Microbiology, Jagiellonian University Medical College, Kraków, Poland
  • Department of Applied Radiobiology, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Cracow Branch, Kraków, Poland
  • Department of Virology, Chair of Microbiology, Jagiellonian University Medical College, Kraków, Poland
  • Department of Gynecological Oncology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Cracow Branch, Kraków, Poland
  • Department of Virology, Chair of Microbiology, Jagiellonian University Medical College, Kraków, Poland
  • Abreu AL, Souza RP, Gimenes F, Consolaro ME (2012) A review of methods for detect human Papillomavirus infection. Virol J 9: 262.
  • Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44: 1755-1762.
  • Biesaga B, Szostek S, Klimek M, Jakubowicz J, Wysocka J (2012) Comparison of the sensitivity and specificity of real-time PCR and in situ hybridization in HPV16 and 18 detection in archival cervical cancer specimens. Folia Histochem Cytobiol 50: 239-247.
  • Cañadas MP, Darwich L, Sirera G, Cirigliano V, Bofill M, Clotet B, Videla S (2010a) New molecular method for the detection of human papillomavirus type 16 integration. Clin Microbiol Infect 16: 836-842.
  • Cañadas MP, Videla S, Darwich L, Tarrats A, Piñol M, García-Cuyás F, Llatjos M, Alcalde C, Fernández I, Sirera G, Clotet B (2010b) Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women. J Clin Virol 48: 198-201.
  • Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M (2007) Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 106: 549-557.
  • Das BC, Sharma JK, Gopalakrishna V, Luthra UK (1992) Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 73: 2327-2336.
  • de Villiers EM (2013) Cross-roads in the classification of papillomaviruses. Virology 445: 2-10.
  • Dutta S, Chakraborty C, Dutta AK, Mandal RK, Roychoudhury S, Basu P, Panda CK (2015) Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation. J Clin Pathol 68: 206-211.
  • Dyson N, Howley PM, Münger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
  • Evans MF, Adamson CS, von Walstrom GM, Cooper K (2007) Use of multiple displacement amplification in the investigation of human papillomavirus physical status. J Clin Pathol 60: 1135-1139.
  • Faridi R, Zahra A, Khan K, Idrees M (2011) Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J 8: 269.
  • Gallo G, Bibbo M, Bagella L, Zamparelli A, Sanseverino F, Giovagnoli MR, Vecchione A, Giordano A (2003) Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol 56: 532-536.
  • Groves IJ, Coleman N (2015) Pathogenesis of human papillomavirus-associated mucosal disease. J Pathol 235: 527-538.
  • Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W (2007) Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 20: 256-266.
  • Howley PM, Schiller JT, Lowy DR (2013) Papillomaviruses. In Filds Virology. Knipe DM, Howley PM eds, pp 1662-1703. Lippincott Williams & Wilkins, Wolters Kluwer Health, Philadelphia.
  • Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF (2004) Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92: 873-880.
  • Jiang M, Baseman JG, Koutsky LA, Feng Q, Mao C, Kiviat NB, Xi LF (2009) Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR. J Clin Microbiol 47: 521-526.
  • Kulmala SM, Syrjänen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi P, Syrjänen KJ, Johansson BC (2006) Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 59: 513-517.
  • Li H, Yang Y, Zhang R, Cai Y, Yang X, Wang Z, Li Y, Cheng X, Ye X, Xiang Y, Zhu B (2013) Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions. J Clin Virol 56: 342-347.
  • Mazumder Indra D, Singh RK, Mitra S, Dutta S, Chakraborty C, Basu PS, Mondal RK, Roychoudhury S, Panda CK (2011) Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. Gynecol Oncol 123: 597-604.
  • Moscicki AB, Schiffman M, Kjaer S, Villa LL (2006) Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 24 S3/42-51.
  • Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ (2003) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
  • Nagao S, Yoshinouchi M, Miyagi Y, Hongo A, Kodama J, Itoh S, Kudo T (2002) Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol 40: 863-867.
  • Peitsaro P, Johansson B, Syrjänen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40: 886-891.
  • Ribeiro J, Teixeira D, Marinho-Dias J, Monteiro P, Loureiro J, Baldaque I, Medeiros R, Sousa H (2014) Characterization of human papillomavirus genotypes and HPV-16 physical status in cervical neoplasias of women from northern Portugal. Int J Gynaecol Obstet 125: 107-110.
  • Ruutu MP, Kulmala SM, Peitsaro P, Syrjänen SM (2008) The performance of the HPV16 real-time PCR integration assay. Clin Biochem 41: 423-428.
  • Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Prétet JL (2008) Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 46: 3678-3685.
  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
  • Schmidt MT, Olejnik AK, Goździcka-Józefiak A (2005) The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome. Acta Biochim Pol 52: 823-832.
  • Shukla S, Mahata S, Shishodia G, Pande S, Verma G, Hedau S, Bhambhani S, Kumari A, Batra S, Basir SF, Das BC, Bharti AC (2014) Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. Indian J Med Res 139: 531-543.
  • Szostek S, Klimek M, Zawilinska B, Kosz-Vnenchak M (2008) Physical state of human papillomavirus type 16 in cervical cell DNA. Folia Biol (Krakow) 56: 269-271.
  • Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, Kisseljov F, Dürst M, Schneider A, von Knebel Doeberitz M (2008) Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 68: 307-313.
  • zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
  • zur Hausen H (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384: 260-265.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.